Foged C[au] - Search Results

Year	Number of Results
1993	3
1994	3
1995	3
1996	5
1997	2
1998	2
1999	2
2000	2
2001	2
2002	1
2004	2
2005	1
2006	1
2007	5
2008	4
2009	4
2010	8
2011	11
2012	12
2013	7
2014	11
2015	8
2016	7
2017	8
2018	15
2019	12
2020	7
2021	6
2022	5
2023	3

1

Delivery of oligonucleotide-based therapeutics: challenges and opportunities.

Hammond SM, Aartsma-Rus A, Alves S, Borgos SE, Buijsen RAM, Collin RWJ, Covello G, Denti MA, Desviat LR, Echevarría L, Foged C, Gaina G, Garanto A, Goyenvalle AT, Guzowska M, Holodnuka I, Jones DR, Krause S, Lehto T, Montolio M, Van Roon-Mom W, Arechavala-Gomeza V. Hammond SM, et al. Among authors: foged c. EMBO Mol Med. 2021 Apr 9;13(4):e13243. doi: 10.15252/emmm.202013243. Epub 2021 Apr 6. EMBO Mol Med. 2021. PMID: 33821570 Free PMC article. Review.

2

The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.

Frederiksen LSF, Zhang Y, Foged C, Thakur A. Frederiksen LSF, et al. Among authors: foged c. Front Immunol. 2020 Jul 21;11:1817. doi: 10.3389/fimmu.2020.01817. eCollection 2020. Front Immunol. 2020. PMID: 32793245 Free PMC article. Review.

3

Opportunities and Challenges in the Delivery of mRNA-based Vaccines.

Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Wadhwa A, et al. Among authors: foged c. Pharmaceutics. 2020 Jan 28;12(2):102. doi: 10.3390/pharmaceutics12020102. Pharmaceutics. 2020. PMID: 32013049 Free PMC article. Review.

4

alpha,alpha'-trehalose 6,6'-dibehenate in non-phospholipid-based liposomes enables direct interaction with trehalose, offering stability during freeze-drying.

Christensen D, Kirby D, Foged C, Agger EM, Andersen P, Perrie Y, Nielsen HM. Christensen D, et al. Among authors: foged c. Biochim Biophys Acta. 2008 May;1778(5):1365-73. doi: 10.1016/j.bbamem.2008.01.013. Epub 2008 Jan 26. Biochim Biophys Acta. 2008. PMID: 18261458 Free article.

5

Stabilization of liposomes during drying.

Ingvarsson PT, Yang M, Nielsen HM, Rantanen J, Foged C. Ingvarsson PT, et al. Among authors: foged c. Expert Opin Drug Deliv. 2011 Mar;8(3):375-88. doi: 10.1517/17425247.2011.553219. Epub 2011 Feb 4. Expert Opin Drug Deliv. 2011. PMID: 21294603 Review.

6

Targeting vaccines to dendritic cells.

Foged C, Sundblad A, Hovgaard L. Foged C, et al. Pharm Res. 2002 Mar;19(3):229-38. doi: 10.1023/a:1014474414097. Pharm Res. 2002. PMID: 11934227 Review.

7

Formulation of RNA interference-based drugs for pulmonary delivery: challenges and opportunities.

Thanki K, Blum KG, Thakur A, Rose F, Foged C. Thanki K, et al. Among authors: foged c. Ther Deliv. 2018 Oct;9(10):731-749. doi: 10.4155/tde-2018-0029. Ther Deliv. 2018. PMID: 30277138 Review.

8

Cell-penetrating peptides for drug delivery across membrane barriers.

Foged C, Nielsen HM. Foged C, et al. Expert Opin Drug Deliv. 2008 Jan;5(1):105-17. doi: 10.1517/17425247.5.1.105. Expert Opin Drug Deliv. 2008. PMID: 18095931 Review.

9

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.

Xu Y, Thakur A, Zhang Y, Foged C. Xu Y, et al. Among authors: foged c. Pharmaceutics. 2021 Jan 28;13(2):177. doi: 10.3390/pharmaceutics13020177. Pharmaceutics. 2021. PMID: 33525500 Free PMC article. Review.

10

Thermostable Subunit Vaccines for Pulmonary Delivery: How Close Are We?

Foged C. Foged C. Curr Pharm Des. 2016;22(17):2561-76. doi: 10.2174/1381612822666160202141603. Curr Pharm Des. 2016. PMID: 26831645 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results